Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Malin Corporation

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 13
Average round size
info
The average size of a deal this fund participated in
$43M
Portfolio companies 9
Rounds per year 1.86
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.31
Exits 4
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Biopharma
  • Genetics
Summary

Malin Corporation is the famous Corporate Investor, which was founded in 2014. The fund was located in Europe if to be more exact in Ireland. The main department of described Corporate Investor is located in the Dublin.

Among the most popular fund investment industries, there are Medical, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Xenex, Artizan Biosciences, 3D4Medical.com. The fund has exact preference in a number of founders of portfolio startups. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.

Deals in the range of 50 - 100 millions dollars are the general things for fund. The real fund results show that this Corporate Investor is 38 percentage points more often commits exit comparing to other companies. Opposing the other organizations, this Malin Corporation works on 21 percentage points less the average amount of lead investments. The high activity for fund was in 2015. The higher amount of exits for fund were in 2019. The fund is generally included in 2-6 deals every year. The average startup value when the investment from Malin Corporation is 10-50 millions dollars.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Malin Corporation, startups are often financed by Wellcome Trust, Targeted Technology Fund, RK Ventures Group. The meaningful sponsors for the fund in investment in the same round are Woodford Investment Management, Vivo Capital, Longitude Capital. In the next rounds fund is usually obtained by Vivo Capital, Longitude Capital, Bill & Melinda Gates Foundation.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Malin Corporation:
Typical Co-investors
Malin Corporation is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Malin Corporation:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Acko Technology and Services -
Aquiline Technology Growth New York, New York, United States
BankInvest Copenhagen, Denmark, Hovedstaden
BIG BOOSTER France, Lyon, Rhone-Alpes
Bradley Family Trust Milwaukee, United States, Wisconsin
Capture Investments -
Dahua Technology Binjiang, China, Jiangxi
EVOLEM -
Footpath Ventures New York, New York, United States
Footprint Ventures Bangalore, India, Karnataka
HC2 Herndon, United States, Virginia
Innovation Factory (Canada) Canada, Hamilton, Ontario
Mountain Internet -
One Financial Holdings New York, New York, United States
Raine Ventures California, San Francisco, United States
Shenzhen Chunshang Capital China, Guangdong, Shenzhen
Staffmark Cincinnati, Ohio, United States
Suzuyo & Co Japan, Shimizu, Shizuoka Prefecture
TOTVS Brazil, São Paulo, Sao Paulo
UpAccelerate -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Poseida Therapeutics

Biotechnology
Genetics
Therapeutics
$142M22 Apr 2019 San Diego, California, United States

Poseida Therapeutics

Biotechnology
Genetics
Therapeutics
$30M03 Apr 2018 San Diego, California, United States

Poseida Therapeutics

Biotechnology
Genetics
Therapeutics
$11M02 Aug 2017 San Diego, California, United States

Xenex

Health Care
Hospital
Medical Device
Robotics
$38M24 Feb 2017 San Antonio, Texas, United States

Artizan Biosciences

Biopharma
Biotechnology
Life Science
06 Feb 2017 New York, United States

Wren Therapeutics

Biopharma
Biotechnology
Health Care
Pharmaceutical
16 Jan 2017 Cambridge, England, United Kingdom

Kymab

Biopharma
Biotechnology
Drug Discovery
Pharmaceuticals
Therapeutics
$100M24 Nov 2016 United Kingdom, England

Poseida Therapeutics

Biotechnology
Genetics
Therapeutics
$23M23 Dec 2015 San Diego, California, United States

3D4Medical.com

3D Technology
Fitness
Health Care
Medical
$16M07 Jul 2015 County Dublin

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Malin Corporation?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: